Targeting JNK for therapeutic benefit: from junk to gold? (original) (raw)

• Kyriakis, J. M. & Avruch, J. pp54 microtubule-associated protein 2 kinase. A novel serine/threonine protein kinase regulated by phosphorylation and stimulated by poly-L-lysine. J. Biol. Chem. 265, 17355–17363 (1990).
  Article CAS PubMed Google Scholar
• Hibi, M., Lin, A., Smeal, T., Minden, A. & Karin, M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7, 2135–2148 (1993).
  Article CAS PubMed Google Scholar
• Adler, V., Polotskaya, A., Wagner, F. & Kraft, A. S. Affinity-purified c-Jun amino-terminal protein kinase requires serine/threonine phosphorylation for activity. J. Biol. Chem. 267, 17001–17005 (1992).
  Article CAS PubMed Google Scholar
• Derijard, B. et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025–1037 (1994).
  Article CAS PubMed Google Scholar
• Kyriakis, J. M. et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369, 156–160 (1994).
  Article CAS PubMed Google Scholar
• Davis, R. J. Signal transduction by the JNK group of MAP kinases. Cell 103, 239–252 (2000). A concise overview of the components of the three mitogen-activated protein kinase signalling pathways and their therapeutic potential.
  Article CAS PubMed Google Scholar
• Gupta, S. et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15, 2760–2770 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Ventura, J. J., Kennedy, N. J., Lamb, J. A., Flavell, R. A. & Davis, R. J. c-Jun NH2-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor. Mol. Cell Biol. 23, 2871–2882 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Tournier, C. et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288, 870–874 (2000).
  Article CAS PubMed Google Scholar
• Lawler, S., Fleming, Y., Goedert, M. & Cohen, P. Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro. Curr. Biol. 8, 1387–1390 (1998).
  Article CAS PubMed Google Scholar
• Tournier, C. et al. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev. 15, 1419–1426 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Enslen, H. & Davis, R. J. Regulation of MAP kinases by docking domains. Biol. Cell 93, 5–14 (2001).
  Article CAS PubMed Google Scholar
• Morrison, D. & Davis, R. J. MAP kinase scaffold proteins in mammals. Annu. Rev. Dev. Cell Biol. (in the press).
• Harper, S. J. & LoGrasso, P. Inhibitors of the JNK signaling pathway. Drugs of the Future 26, 957–973 (2001). An excellent review of progress in the discovery of inhibitors of JNK signalling, including recent patent activity.
  Article CAS Google Scholar
• Maroney, A. C. et al. CEP-1347 (KT7515), a synthetic inhibitor of the mixed lineage kinase family. J. Biol. Chem. 276, 25302–25308 (2001). A detailed description of an inhibitor of JNK signalling that functions upstream of the JNKs.
  Article CAS PubMed Google Scholar
• Manning, A. M. & Mercurio, F. Transcription inhibitors in inflammation. Exp. Opin. Invest. Drugs 6, 555–567 (1997).
  Article CAS Google Scholar
• Swantek, J. L., Cobb, M. H. & Geppert, T. D. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor-α (TNF-α) translation: glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK. Mol. Cell. Biol. 17, 6274–6282 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Ishizuka, T. et al. Mast cell tumor necrosis factor α production is regulated by MEK kinases. Proc. Natl Acad. Sci. USA 94, 6358–6363 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Gum, R., Wang, H., Lengyel, E., Juarez, J. & Boyd, D. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14, 1481–1493 (1997).
  Article CAS PubMed Google Scholar
• Han, Z. et al. Jun-N-terminal kinase in rheumatoid arthritis. J. Pharm. Exp. Therap. 291, 124–130 (1999).
  CAS Google Scholar
• Han, Z. et al. c-Jun N-terminal kinase is required for metalloproteinase (MMP) expression in synoviocytes and regulates bone destruction in adjuvant arthritis. J. Clin. Invest. 108, 73–81 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Clancy, R. et al. Activation of stress-activated protein kinase in osteoarthritis cartilage: evidence for nitric oxide dependence. Osteoarthritis Cartilage 9, 294–299 (2002).
  Article Google Scholar
• Bennett, B. L. et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl Acad. Sci. USA 98, 13681–13686 (2001). The first detailed description of the pharmacologic profile of a selective JNK inhibitor.
  Article CAS PubMed PubMed Central Google Scholar
• Han, Z., Chang, L., Yamanishi, Y., Karin, M. & Firestein, G. S. Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis. Arthritis Rheum. 46, 818–823 (2002).
  Article CAS PubMed Google Scholar
• Eynott, P. R., Adcock, I. M. & Chung, P. The effects of selective c-Jun N-terminal kinase inhibition in a sensitized Brown Norway rat model of allergic asthma. Am. J. Respir. Crit. Care Med. 49, S102 (2001).
  Google Scholar
• Sabapathy, K. et al. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr. Biol. 9, 116–125 (1999).
  Article CAS PubMed Google Scholar
• Rincon, M. et al. The JNK pathway regulates the in vivo deletion of immature CD4+CD8+ thymocytes. J. Exp. Med. 188, 1817–1830 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Dong, C. et al. JNK is required for effector T-cell function but not for T-cell activation. Nature 405, 91–94 (2000).
  Article CAS PubMed Google Scholar
• Dong, C. et al. Defective T cell differentiation in the absence of Jnk1. Science 282, 2092–2095 (1998).
  Article CAS PubMed Google Scholar
• Yang, D. D. et al. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity 9, 575–585 (1998).
  Article CAS PubMed Google Scholar
• Arbour, N. et al. c-Jun NH2-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8+ T cell-mediated antiviral immunity. J. Exp. Med. 195, 801–810 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Conze, D. et al. c-Jun NH2-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8+ T cell activation. J. Exp. Med. 195, 811–823 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Su, B. et al. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77, 727–736 (1994).
  Article PubMed Google Scholar
• Li, W., Whaley, C. D., Mondino, A. & Mueller, D. L. Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells. Science 271, 1272–1276 (1996).
  Article CAS PubMed Google Scholar
• Rincon, M., Flavell, R. A. & Davis, R. J. Signal transduction by MAP kinases in T lymphocytes. Oncogene 20, 2490–2497 (2001)
  Article CAS PubMed Google Scholar
• Kuan, C. Y. et al. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22, 667–676 (1999).
  Article CAS PubMed Google Scholar
• Yang, D. D. et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865–870 (1997).
  Article CAS PubMed Google Scholar
• Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J. & Greenberg, M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326–1331 (1995).
  Article CAS PubMed Google Scholar
• Le-Niculescu, H. et al. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol. Cell Biol. 19, 751–763 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Bruckner, S. R. et al. JNK3 contributes to c-Jun activation and apoptosis but not oxidative stress in nerve growth factor-deprived sympathetic neurons. J. Neurochem. 78, 298–303 (2001).
  Article CAS PubMed Google Scholar
• Scheuner, D. et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864–870 (1996).
  Article CAS PubMed Google Scholar
• Morishima, Y. et al. β-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J. Neurosci. 21, 7551–7560 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Zhu, X. et al. Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease J. Neurochem. 76, 435–441 (2001).
  Article CAS PubMed Google Scholar
• Pei, J -J. et al. Localization of active forms of c-Jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration. J. Alzheimer's Dis. 3, 41–48 (2001).
  Article CAS Google Scholar
• Reynolds, C. H., Utton, M. A., Gibb, G. M., Yates, A. & Anderton, B. H. Stress-activated protein kinase/c-Jun N-terminal kinase phosphorylates Tau protein. J. Neurochem. 68, 1736–1744 (1997).
  Article CAS PubMed Google Scholar
• Shoji, M. et al. JNK activation is associated with intracellular β-amyloid accumulation. Mol. Brain Res. 85, 221–233 (2001).
  Article Google Scholar
• Reynolds, C. H., Betts, J. C., Blackstock, W. P., Nebreda, A. R. & Anderton, B. H. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and p38, and glycogen synthase kinase-3β. J. Neurochem. 74, 1587–1595 (2001).
  Article Google Scholar
• Anglade, P. et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12, 25–31 (1997).
  CAS PubMed Google Scholar
• Xia, X. G. et al. Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc. Natl Acad. Sci. USA 98, 10433–10438 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Mattson, M. P. Apoptosis in neurodegenerative disorders. Nature Rev. Mol. Cell Biol. 1, 120–129 (2000).
  Article CAS Google Scholar
• Herdegen, T. et al. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J. Neurosci. 18, 5124–5135 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Must, A. et al. The disease burden associated with overweight and obesity. JAMA 282, 1523–1529 (1999).
  Article CAS PubMed Google Scholar
• Facchini, F. S., Hua, N. W., Reaven, G. M. & Stoohs, R. A. Hyperinsulinemia: the missing link among oxidative stress and age-related diseases? Free Rad. Biol. Med. 29, 1302–1306 (2000).
  Article CAS PubMed Google Scholar
• Uysal, K. T., Wiesbrock, S. M., Marino, M. W. & Hotamisligil, G. S. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389, 610–614 (1997).
  Article CAS PubMed Google Scholar
• Withers, D. J. & White, M. F. Insulin action and type 2 diabetes: lessons from knockout mice. Curr. Opin. Endocrinol. Diab. 6, 141–145 (1999).
  Article CAS Google Scholar
• Withers, D. J. et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900–904 (1998).
  Article CAS PubMed Google Scholar
• Lee, Y. H., Giraud, J., Davis, R. J. & White, M. F. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J. Biol. Chem. 278, 2896–2902 (2003).
  Article CAS PubMed Google Scholar
• Standaert, M. L. et al. Effects of knockout of the protein kinase C β gene on glucose transport and glucose homeostasis. Endocrinology 140, 4470–4477 (1999).
  Article CAS PubMed Google Scholar
• Hirosumi, J. et al. A central role for JNK in obesity and insulin resistance. Nature 420, 333–337 (2002).
  Article CAS PubMed Google Scholar
• Adjei, A. A. Blocking oncogenic Ras signaling for cancer therapy. J. Natl Cancer Inst. 93, 1062–1074 (2001). A review of different approaches to Ras inhibition, including targeting JNK.
  Article CAS PubMed Google Scholar
• Smeal, T., Binetruy, B., Mercola, D. A., Birrer, M. & Karin, M. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354, 494–496 (1991).
  Article CAS PubMed Google Scholar
• Schutte, J., Minna, J. D. & Birrer, M. J. Deregulated expression of human c-Jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene. Proc. Natl Acad. Sci. USA 86, 2257–2261 (1989).
  Article CAS PubMed PubMed Central Google Scholar
• Johnson, R., Spiegelman, B., Hanahan, D. & Wisdom, R. Cellular transformation and malignancy induced by ras require c-Jun. Mol. Cell Biol. 16, 4504–4511 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Eferl, R. et al. Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112, 181–192 (2003).
  Article CAS PubMed Google Scholar
• Schreiber, M. et al. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13, 607–619 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Ip, Y. T. & Davis, R. J. Signal transduction by the c-Jun N-terminal kinase (JNK) — from inflammation to development. Curr. Opin. Cell Biol. 10, 205–219 (1998).
  Article CAS PubMed Google Scholar
• Potapova, O. et al. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem. 272, 14041–14044 (1997).
  Article CAS PubMed Google Scholar
• Potapova, O. et al. c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells. J. Biol. Chem. 275, 24767–24775 (2000).
  Article CAS PubMed Google Scholar
• Behrens, A., Jochum, W., Sibilia, M. & Wagner, E. F. Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene 9, 2657–2663 (2000).
  Article CAS Google Scholar
• Kennedy, N. J. et al. Suppression of Ras-stimulated transformation by the JNK signal transduction pathway. Genes Dev. 17, 629–637 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Lei, K. et al. The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH2-terminal kinase. Mol. Cell Biol. 22, 4929–4942 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Yoshida, S. et al. The c-Jun NH2-terminal kinase 3 (JNK3) gene: genomic structure, chromosomal assignment, and loss of expression in brain tumors. J. Hum. Genet. 46, 182–187 (2001).
  Article CAS PubMed Google Scholar
• Nishina, H. et al. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 385, 350–353 (1997).
  Article CAS PubMed Google Scholar
• Tournier, C. et al. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev. 15, 1419–1426 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Teng, D. H. et al. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res. 57, 4177–4182 (1997).
  CAS PubMed Google Scholar
• Kim, H. L. et al. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Res. 61, 2833–2837 (2001).
  CAS PubMed Google Scholar
• Yoshida, B. A. et al. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res. 59, 5483–5487 (1999).
  CAS PubMed Google Scholar
• Yamada, S. D. et al. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma. Cancer Res. 62, 6717–6723 (2002).
  CAS PubMed Google Scholar
• Hess, P., Pihan, G., Sawyers, C. L., Flavell, R. A. & Davis, R. J. Survival signaling mediated by c-Jun NH2-terminal kinase in transformed B lymphoblasts. Nature Genet. 32, 201–205 (2002).
  Article CAS PubMed Google Scholar
• Dumas, J. Protein kinase inhibitors: emerging pharmacophores 1997–2000. Exp. Opin. Ther. Patents 11, 405–429 (2001). An excellent review of the many different kinase inhibitor chemical templates that were identified in the late 1990s.
  Article CAS Google Scholar
• Gray, N. S. et al. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science 281, 533–538 (1998).
  Article CAS PubMed Google Scholar
• Zhang, F., Strand, A., Robbins, D., Cobb, M. H. & Goldsmith, E. J. Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution. Nature 367, 704–711 (1994).
  Article CAS PubMed Google Scholar
• Wilson, K. P. et al. Crystal structure of p38 mitogen-activated protein kinase. J. Biol. Chem. 271, 27696–27700 (1996).
  Article CAS PubMed Google Scholar
• Xie, X. et al. Crystal structure of JNK3: a kinase implicated in neuronal apoptosis. Structure 6, 983–991 (1998). The report of the JNK3 crystal structure provided a key tool for the identification of selective JNK inhibitors.
  Article CAS PubMed Google Scholar
• Bennett, B. L. et al. WO 0112609 (2001).
• Bain, J., McLauchlan, H., Elliott, M. & Cohen, P. The specificities of protein kinase inhibitors: an update. Biochem. J. 371, 199–204 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Kois, A. et al. WO 200246170 (2002).
• Press release, dated 10/21/2002; see http://www.corporate-ir.net/ireye/ir_site.zhtml?ticker=celg&script=410&layout=9&item_id=346725.A press release announcing the first Phase I clinical trial of a selective JNK inhibitor.
• Halazy, S., Church, D., Camps, M. & Gotteland, J. P. WO 0147920 (2001).
• Arkinstall, S. et al. WO 0123379 (2001).
• Arkinstall, S. et al. WO 0123378 (2001).
• Arkinstall, S. et al. WO 0123382 (2001).
• Salituro, F. G. et al. WO 0064872 (2000).
• Green, J. et al. WO 0112621 (2001).
• Ohkawa, S., Naruo, K., Miwatashi, S., Kimura, H. & Kawamoto, T. WO 2002062792 (2002).
• Corbett, W. L. & Luk, K. -C. & Mahaney, P. E. WO 0035909 (2000).
• Luk, K. -C., Mahaney, P. E. & Mischke, S. G. WO 0035906 (2000).
• Luk, K. -C. & Michoud, C. WO 0035921 (2000).
• Radcliffe, A. J. et al. WO 2003024967 (2003).
• Oinuma, H., Ohi, N., Sato, N. & Seshimo, H. WO 2002083648 (2002).
• Graczyk, P. et al. WO 2002081475 (2002).
• Lograsso, P. et al. WO 200191749 (2001).
• Weston, C. R. & Davis, R. J. The JNK signal transduction pathway. Curr. Opin. Genet. Dev. 12, 14–21 (2002).
  Article CAS PubMed Google Scholar